Raymond James & Associates’s Marchex MCHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-199,189
Closed -$753K 3629
2019
Q4
$753K Sell
199,189
-2,593
-1% -$9.32K ﹤0.01% 2451
2019
Q3
$634K Buy
201,782
+691
+0.3% +$2.66K ﹤0.01% 2494
2019
Q2
$945K Sell
201,091
-164,449
-45% -$786K ﹤0.01% 2249
2019
Q1
$1.73M Buy
365,540
+92,811
+34% +$379K ﹤0.01% 1850
2018
Q4
$723K Sell
272,729
-2,526
-0.9% -$7.11K ﹤0.01% 2297
2018
Q3
$765K Buy
275,255
+152,482
+124% +$437K ﹤0.01% 2423
2018
Q2
$376K Buy
122,773
+17,899
+17% +$50K ﹤0.01% 2872
2018
Q1
$286K Buy
+104,874
New +$339K ﹤0.01% 2909

Other funds holding MCHX

Raymond James & Associates's MCHX Position: Q1 2020 in Review

Raymond James & Associates sold out of Marchex (MCHX) in Q1 2020, closing a stake of 199,189 shares — an estimated $753K sold.

Raymond James & Associates first reported a position in MCHX in Q1 2018 and held it in 8 quarters. The position peaked at $1.73M in Q1 2019. 76 funds tracked by Wall St. Rank hold MCHX as of Q1 2020.

  • Raymond James & Associates reported no remaining Marchex position as of Q1 2020 after selling out during the quarter.
  • Raymond James & Associates sold 199,189 Marchex shares in Q1 2020, an estimated $753K.
  • Raymond James & Associates first reported a position in Marchex in Q1 2018 and held it in 8 quarters.
  • Raymond James & Associates's Marchex position peaked at $1.73M in Q1 2019.
  • 76 funds tracked by Wall St. Rank held Marchex as of Q1 2020.

Based on Raymond James & Associates's 13F filing for Q1 2020, filed 21 Apr 2020.